Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
iSolveSM information on demand is the result of our focus on customer relationship
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Ayush is expanding beyond wellness to therapeutic wellness
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Subscribe To Our Newsletter & Stay Updated
